compartir en google+ compartir en facebook Compartir en Twitter compartir en Linkedin

Otras publicaciones

Publicaciones GT EPOC 2020

Almagro P, Boixeda R, Diez-Manglano J, Gómez-Antúnez M, López-García F, Recio J. Insights into Chronic Obstructive Pulmonary Disease as Critical Risk Factor for Cardiovascular Disease. Int J Chron Obstruct Pulmon Dis. 2020 Apr 14;15:755-764. doi: 10.2147/COPD.S238214. eCollection 2020. Review.

Publicaciones GT Enf. Tromboembólica 2020

Blondon M, Jimenez D, Robert-Ebadi H, Del Toro J, Lopez-Jimenez L, Falga C, Skride A, Font L, Vazquez FJ, Bounameaux H, Monreal M; RIETE investigators.. Comparative clinical prognosis of massive and non-massive pulmonary embolism: a registry-based cohort study. J Thromb Haemost. 2020 Oct 29. doi: 10.1111/jth.15146. [Epub ahead of print]

Publicaciones GT bioética 2020

Herreros B, Benito M, Gella P, Valenti E, Sánchez B, Velasco T. Why have Advance Directives failed in Spain? BMC Med Ethics. 2020 Nov 16;21(1):113. doi: 10.1186/s12910-020-00557-4.

Time to Stop the Tragedy in Spanish Nursing Homes during the COVID-19 Pandemic

Letter to the Editor

Autores: Bernabeu-Wittel M, Gómez-Huelgas R, Nieto-Martín MD; SEMI-COVID-19 Network.

J Am Geriatr Soc. 2020 Nov 12. doi: 10.1111/jgs.16943. Online ahead of print.

Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study

Background: Limited evidence exists on the role of glucose-lowering drugs in patients with COVID-19. Our main objective was to examine the association between in-hospital death and each routine at-home glucose-lowering drug both individually and in combination with metformin in patients with type 2 diabetes mellitus admitted for COVID-19.

Predicting Clinical Outcome with Phenotypic Clusters in COVID-19 Pneumonia: An Analysis of 12,066 Hospitalized Patients from the Spanish Registry SEMI-COVID-19

(1) Background: Different clinical presentations in COVID-19 are described to date, from mild to severe cases. This study aims to identify different clinical phenotypes in COVID-19 pneumonia using cluster analysis and to assess the prognostic impact among identified clusters in such patients. (2) Methods: Cluster analysis including 11 phenotypic variables was performed in a large cohort of 12,066 COVID-19 patients, collected and followed-up from 1 March to 31 July 2020, from the nationwide Spanish Society of Internal Medicine (SEMI)-COVID-19 Registry.

Clinical Characteristics and Risk Factors for Mortality in Very Old Patients Hospitalized with COVID-19 in Spain

Background: Advanced age is a well-known risk factor for poor prognosis in COVID-19. However, few studies have specifically focused on very old inpatients with COVID-19. This study aims to describe the clinical characteristics of very old inpatients with COVID-19 and identify risk factors for in-hospital mortality at admission.

Admission hyperglycemia as a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: Data from the Spanish SEMI-COVID-19 Registry

Background: Hyperglycaemia has emerged as an important risk factor for death in coronavirus disease 2019 (COVID-19). The aim of this study was to evaluate the association between blood glucose (BG) levels and in-hospital mortality in non-critically patients hospitalized with COVID-19.

Association of Hypertension with All-Cause Mortality among Hospitalized Patients with COVID-19

It is unclear to which extent the higher mortality associated with hypertension in the coronavirus disease (COVID-19) is due to its increased prevalence among older patients or to specific mechanisms. Cross-sectional, observational, retrospective multicenter study, analyzing 12226 patients who required hospital admission in 150 Spanish centers included in the nationwide SEMI-COVID-19 Network. We compared the clinical characteristics of survivors versus non-survivors. The mean age of the study population was 67.5 ± 16.1 years, 42.6% were women. Overall, 2630 (21.5%) subjects died.

Síntomas menores y COVID-19. Protocolo de actuación en Farmacia Comunitaria

Autores:

Javier Plaza Zamora, Guillermo Estrada Riolobos, Jesús C. Gómez Martínez, Vicente J. Baixauli Fernández, Ana Molinero Crespo, Eduardo Satué de Velasco, Luis Salar Ibáñez, Neus Caelles Franch (SEFAC)

Vicente Martín Sánchez, Vicente Olmo Quintana (SEMERGEN)

Juan González Armengol (SEMES)
Ma Isabel Gutiérrez Pérez (SEMFYC) Lorenzo Armenteros del Olmo (SEMG) Ricardo Gómez Huelgas (SEMI)

Concepción Prados Sánchez y Alberto Mangas Moro (SEPAR)

Páginas